LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$6.96 USD
+0.07 (1.02%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $6.95 -0.01 (-0.14%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for LifeStance Health Group, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,056 | 860 | 668 | 266 | 324 |
Cost Of Goods | 754 | 623 | 466 | 179 | 229 |
Gross Profit | 302 | 237 | 202 | 86 | 95 |
Selling & Adminstrative & Depr. & Amort Expenses | 491 | 447 | 488 | 80 | 71 |
Income After Depreciation & Amortization | -189 | -210 | -286 | 7 | 24 |
Non-Operating Income | 4 | -3 | -8 | -5 | -35 |
Interest Expense | 21 | 20 | 39 | 19 | 8 |
Pretax Income | -207 | -233 | -333 | -17 | -19 |
Income Taxes | -20 | -17 | -26 | -4 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -186 | -216 | -307 | -13 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -186 | -216 | -307 | -13 | -19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -107 | -139 | -230 | 35 | 34 |
Depreciation & Amortization (Cash Flow) | 83 | 71 | 56 | 28 | 10 |
Income After Depreciation & Amortization | -189 | -210 | -286 | 7 | 24 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 367.46 | 355.28 | 327.52 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.51 | -0.61 | -1.05 | NA | NA |
Diluted Net EPS (GAAP) | -0.51 | -0.61 | -1.05 | -0.01 | NA |
Fiscal Year end for LifeStance Health Group, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 312.33 | 300.44 | 280.60 | 262.90 |
Cost Of Goods | NA | 214.53 | 205.71 | 197.29 | 186.69 |
Gross Profit | NA | 97.81 | 94.73 | 83.31 | 76.21 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 113.75 | 111.49 | 115.59 | 150.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -15.94 | -16.76 | -32.28 | -74.36 |
Non-Operating Income | NA | -0.85 | 1.94 | -0.51 | 1.87 |
Interest Expense | NA | 5.82 | 5.90 | 5.53 | 5.48 |
Pretax Income | NA | -22.62 | -20.73 | -38.32 | -77.97 |
Income Taxes | NA | 0.66 | 0.36 | 6.64 | -16.39 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -23.28 | -21.10 | -44.96 | -61.58 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -23.28 | -21.10 | -44.96 | -61.58 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 379.43 | 376.33 | 367.46 | 372.48 |
Diluted EPS Before Non-Recurring Items | NA | -0.06 | -0.06 | -0.12 | -0.17 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.06 | -0.12 | -0.17 |